In a phone interview, chief innovation officer Roy Rosin discussed how Penn Medicine is approaching behavior change, allowing clinicians to receive needed patient data and helping patients get to the best site of care.
Philadelphia-based health data management startup HealthVerity recently raised a $25 million Series C financing round led by Foresite Capital.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
The duo will utilize Babyscripts' remote monitoring tech along with information gained from Penn Medicine's Heart Safe Motherhood program.
Shares of Philadelphia-based Spark were up more than 120 percent in premarket trading on the Nasdaq following the news.
In a phone Q&A, Nash, the founding dean of the Jefferson College of Population Health and the co-host of the 19th annual Population Health Colloquium, muses on precision medicine, social determinants of health and the future of pop health.
The round, which included funding from investors like Sopris Capital and Fresenius Medical Care Ventures, will be used to advance Tridiuum's solution aimed at integrating behavioral health into the continuum of care.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The company currently has a product candidate in the late-discovery phase, an EGFR-targeting drug for lung cancer that would go after a resistance mechanism against existing kinase inhibitors.
The University City Science Center's DHA program created a blind initial application process that focuses on the founders’ ability to communicate their idea with the goal of removing biases associated with how screeners perceive the founding team.
The Philadelphia-based company has an IND open with the FDA and plans to begin its clinical trial in the first half of next year.
The Philadelphia company, which enabled organizations to create secure digital health applications, had raised capital from Safeguard Scientifics, Dreamit Ventures, Robin Hood Ventures and Ben Franklin Technology Partners and had customers like Thomas Jefferson University Hospitals and the American Heart Association.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Cigna has been pushing heavily into digital health as evidenced by a venture capital arm it launched earlier this year as well as acquisitions like its 2017 purchase of digital practice management company Brighter.
The company plans to file an IND in the second half of 2019. The company CEO says the "CAAR-T" therapies may avoid some of the potentially fatal toxicity risks of CAR-Ts for blood cancers.
A fireside chat at MedCity INVEST Twin Cities event between Medical Alley Association CEO and President Shaye Mandle and Gary Zimmer, chief medical advisor for Comcast Digital Health and general manager of the two companies' joint venture, 1819 LLC, shed some light on what the hope is for the partnership's potential.
The CEO of the largest medical device industry association believes The Bleeding Edge documentary to be "entertainment" and not fact-based. What it represents, rather, is an inconvenient truth.
A manufacturing error during a clinical trial of Kymriah, now marketed by Novartis, is less likely today, but could be an issue as CAR-Ts move into earlier therapy lines.